Page last updated: 2024-12-07

1,3-dimethyl-2-cyano-1-nitrosoguanidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

1,3-dimethyl-2-cyano-1-nitrosoguanidine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID126526
MeSH IDM0174227

Synonyms (9)

Synonym
cyanodmng
75511-49-8
3-cyano-1,2-dimethyl-1-nitrosoguanidine
AKOS006377019
guanidine, n'-cyano-n,n''-dimethyl-n-nitroso-
A839677
3-cyano-1,2-dimethyl-1-nitroso-guanidine
1,3-dimethyl-2-cyano-1-nitrosoguanidine
DTXSID60226461

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In trials using 50 microM CyanoDMNG (5 mL dosing solutions), it was demonstrated that hepatocytes are capable of denitrosating a 40 microM concentration of the applied compound with little change in the total or oxidized glutathione levels."( Denitrosation of 1,3-dimethyl-2-cyano-1-nitrosoguanidine in rat primary hepatocyte cultures.
Belka, GK; Dworkin, C; Jensen, DE, 1997
)
0.64
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (85.71)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]